Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN.

Cancer. 2014 Dec 1;120(23):3627-34. doi: 10.1002/cncr.29038. Epub 2014 Sep 10.

PMID:
25209362
[PubMed - in process]
2.

Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.

Radkay LA, Chiosea SI, Seethala RR, Hodak SP, LeBeau SO, Yip L, McCoy KL, Carty SE, Schoedel KE, Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2014 Aug 12. doi: 10.1002/cncy.21474. [Epub ahead of print]

PMID:
25132659
[PubMed - as supplied by publisher]
3.

A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.

Yip L, Wharry LI, Armstrong MJ, Silbermann A, McCoy KL, Stang MT, Ohori NP, LeBeau SO, Coyne C, Nikiforova MN, Bauman JE, Johnson JT, Tublin ME, Hodak SP, Nikiforov YE, Carty SE.

Ann Surg. 2014 Jul;260(1):163-8. doi: 10.1097/SLA.0000000000000215.

PMID:
24901361
[PubMed - indexed for MEDLINE]
4.

Molecular approaches to thyroid cancer diagnosis.

Hsiao SJ, Nikiforov YE.

Endocr Relat Cancer. 2014 Oct;21(5):T301-13. doi: 10.1530/ERC-14-0166. Epub 2014 May 14.

PMID:
24829266
[PubMed - in process]
5.

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.

Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE.

Thyroid. 2014 Sep;24(9):1369-74. doi: 10.1089/thy.2014.0067. Epub 2014 Jul 16.

PMID:
24798894
[PubMed - in process]
6.

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer.

Kelly LM, Barila G, Liu P, Evdokimova VN, Trivedi S, Panebianco F, Gandhi M, Carty SE, Hodak SP, Luo J, Dacic S, Yu YP, Nikiforova MN, Ferris RL, Altschuler DL, Nikiforov YE.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4233-8. doi: 10.1073/pnas.1321937111. Epub 2014 Feb 3.

PMID:
24613930
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.

Dettmer MS, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN.

J Mol Endocrinol. 2014 Mar 6;52(2):181-9. doi: 10.1530/JME-13-0266. Print 2014 Apr.

PMID:
24443580
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

RET rearrangements in lung adenocarcinoma and radiation.

Dacic S, Luvison A, Evdokimova V, Kelly L, Siegfried JM, Villaruz LC, Socinski MA, Nikiforov YE.

J Thorac Oncol. 2014 Jan;9(1):118-20. doi: 10.1097/JTO.0000000000000015.

PMID:
24346100
[PubMed - indexed for MEDLINE]
9.

ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.

Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, Bogdanova TI, Evdokimova VN, Hatch M, Zurnadzy LY, Nikiforova MN, Yue NJ, Zhang M, Mabuchi K, Tronko MD, Nikiforov YE.

Cancer. 2014 Mar 15;120(6):799-807. doi: 10.1002/cncr.28484. Epub 2013 Dec 10.

PMID:
24327398
[PubMed - indexed for MEDLINE]
10.

The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations.

Jung CK, Little MP, Lubin JH, Brenner AV, Wells SA Jr, Sigurdson AJ, Nikiforov YE.

J Clin Endocrinol Metab. 2014 Feb;99(2):E276-85. doi: 10.1210/jc.2013-2503. Epub 2013 Nov 18.

PMID:
24248188
[PubMed - indexed for MEDLINE]
11.

SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical laboratory.

Roy S, Durso MB, Wald A, Nikiforov YE, Nikiforova MN.

J Mol Diagn. 2014 Jan;16(1):11-22. doi: 10.1016/j.jmoldx.2013.08.005. Epub 2013 Nov 9.

PMID:
24220144
[PubMed - indexed for MEDLINE]
12.

Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?

Wharry LI, McCoy KL, Stang MT, Armstrong MJ, LeBeau SO, Tublin ME, Sholosh B, Silbermann A, Ohori NP, Nikiforov YE, Hodak SP, Carty SE, Yip L.

World J Surg. 2014 Mar;38(3):614-21. doi: 10.1007/s00268-013-2261-9.

PMID:
24081539
[PubMed - indexed for MEDLINE]
13.

Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.

Mehta RS, Carty SE, Ohori NP, Hodak SP, Coyne C, LeBeau SO, Tublin ME, Stang MT, Johnson JT, McCoy KL, Nikiforova MN, Nikiforov YE, Yip L.

Surgery. 2013 Oct;154(4):730-6; discussion 736-8. doi: 10.1016/j.surg.2013.05.015.

PMID:
24074409
[PubMed - indexed for MEDLINE]
14.

DNA topoisomerases participate in fragility of the oncogene RET.

Dillon LW, Pierce LC, Lehman CE, Nikiforov YE, Wang YH.

PLoS One. 2013 Sep 11;8(9):e75741. doi: 10.1371/journal.pone.0075741. eCollection 2013.

PMID:
24040417
[PubMed - in process]
Free PMC Article
15.

Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules.

Buryk MA, Monaco SE, Witchel SF, Mehta DK, Gurtunca N, Nikiforov YE, Simons JP.

Int J Pediatr Otorhinolaryngol. 2013 Oct;77(10):1697-700. doi: 10.1016/j.ijporl.2013.07.029. Epub 2013 Aug 9.

PMID:
23993207
[PubMed - indexed for MEDLINE]
16.

Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.

Nikiforova MN, Wald AI, Roy S, Durso MB, Nikiforov YE.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1852-60. doi: 10.1210/jc.2013-2292. Epub 2013 Aug 26.

PMID:
23979959
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view.

Ohori NP, Wolfe J, Hodak SP, LeBeau SO, Yip L, Carty SE, Duvvuri U, Schoedel KE, Nikiforova MN, Nikiforov YE.

Cancer Cytopathol. 2013 Dec;121(12):718-28. doi: 10.1002/cncy.21333. Epub 2013 Jul 23.

PMID:
23881852
[PubMed - indexed for MEDLINE]
18.

Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma.

Bansal M, Gandhi M, Ferris RL, Nikiforova MN, Yip L, Carty SE, Nikiforov YE.

Am J Surg Pathol. 2013 Oct;37(10):1586-91. doi: 10.1097/PAS.0b013e318292b780.

PMID:
23797723
[PubMed - indexed for MEDLINE]
19.

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.

Gupta N, Dasyam AK, Carty SE, Nikiforova MN, Ohori NP, Armstrong M, Yip L, LeBeau SO, McCoy KL, Coyne C, Stang MT, Johnson J, Ferris RL, Seethala R, Nikiforov YE, Hodak SP.

J Clin Endocrinol Metab. 2013 May;98(5):E914-22. doi: 10.1210/jc.2012-3396. Epub 2013 Mar 28.

PMID:
23539734
[PubMed - indexed for MEDLINE]
20.

RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.

Leeman-Neill RJ, Brenner AV, Little MP, Bogdanova TI, Hatch M, Zurnadzy LY, Mabuchi K, Tronko MD, Nikiforov YE.

Cancer. 2013 May 15;119(10):1792-9. doi: 10.1002/cncr.27893. Epub 2013 Feb 21.

PMID:
23436219
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk